{
  "actions": [
    {
      "acted_at": "2001-01-30", 
      "references": [
        {
          "reference": "CR S774-776", 
          "type": null
        }
      ], 
      "text": "Sponsor introductory remarks on measure.", 
      "type": "action"
    }, 
    {
      "acted_at": "2001-01-30", 
      "committee": "Committee on Health, Education, Labor, and Pensions", 
      "references": [
        {
          "reference": "CR S776-777", 
          "type": "text of measure as introduced"
        }
      ], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s215-107", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Health, Education, Labor, and Pensions", 
      "committee_id": "SSHR"
    }
  ], 
  "congress": "107", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2001-01-30", 
  "number": "215", 
  "official_title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to permit importation in personal baggage and by mail of certain covered products  for personal use from certain foreign countries and to correct impediments in implementation of the Medicine Equity and Drug Safety Act of 2000.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Medication Equity and Drug Savings Act", 
  "sponsor": {
    "district": null, 
    "name": "Stabenow, Debbie", 
    "state": "MI", 
    "thomas_id": "01531", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2001-01-30", 
  "subjects": [
    "Administrative procedure", 
    "Authorization", 
    "Canada", 
    "Commerce", 
    "Congress", 
    "Congressional oversight", 
    "Congressional reporting requirements", 
    "Contracts", 
    "Department of Health and Human Services", 
    "Drug adulteration", 
    "Drug industry", 
    "Drug therapy", 
    "Drugs", 
    "Fees", 
    "Foreign trade and international finance", 
    "Government operations and politics", 
    "Government paperwork", 
    "Governmental investigations", 
    "Health", 
    "Imports", 
    "Intellectual property", 
    "Labeling", 
    "Law", 
    "Mail-order business", 
    "Patents", 
    "Prescription pricing", 
    "Price discrimination", 
    "Price fixing", 
    "Printing", 
    "Product safety"
  ], 
  "subjects_top_term": "Foreign trade and international finance", 
  "summary": {
    "as": "Introduced", 
    "date": "2001-01-30", 
    "text": "Medication Equity and Drug Savings Act - Amends the Federal Food, Drug, and Cosmetic Act to require regulations permitting the personal-use importation into the United States of covered prescription drugs in personal baggage or by mail.Amends the Medicine Equity and Drug Safety Act of 2000 respecting specified imported pharmaceutical regulations to: (1) eliminate the sunset provision; (2) prohibit manufacturers from imposing importer pricing or labeling conditions, other than label fees; and (3) revise certification and rulemaking conditions."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Medication Equity and Drug Savings Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to amend the Federal Food, Drug, and Cosmetic Act to permit importation in personal baggage and by mail of certain covered products  for personal use from certain foreign countries and to correct impediments in implementation of the Medicine Equity and Drug Safety Act of 2000.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:46:40-05:00"
}